Results 11 to 20 of about 214,511 (232)
Antifungal prophylaxis in stem cell transplantation centers in Turkey [PDF]
Turkish Journal of Hematology, 2011 OBJECTIVE: This study aimed to determine the current state of antifungal prophylaxis in Turkish stem cell transplantation (SCT) centers. METHODS: he were 38 active stem cell transplantation centers in Turkey, 28 of which were registered with the European
Hamdi Akan
doaj +4 more sources
Antifungal Prophylaxis in Solid Organ Transplant Recipients [PDF]
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2015 Solid organ transplantation (SOT) is a treatment method that improves quality of life and survival of patients with end-stage organ failure. Immunosuppressive treatments given to these patients may predispose to the development of invasive fungal ...
Şebnem ŞENOL +18 more
doaj +4 more sources
Antifungal prophylaxis with azole derivatives [PDF]
Clinical Microbiology and Infection, 2004 In recent years, several reports have underlined the increasing role of fungal infections as a cause of morbidity and mortality in hospitalised patients. For this reason, and also in light of the high mortality rate associated with these infections, chemoprophylaxis has been advocated by several authors.
CASTAGNOLA E +3 more
openaire +5 more sources
Prophylaxis of Antifungal Drugs against Systemic Fungemia induced by Oral Candidiasis in Mice
Current Issues in Molecular Biology, 2023 Oral mucositis is highly prevalent among the elderly, for whom oral care is often difficult. Oral mucositis, such as candidiasis, can induce systemic fungemia.
Kazunori Ninomiya +6 more
doaj +2 more sources
Therapeutics and Clinical Risk Management, 2014 Habip Gedik,1 Funda Şimşek,1 Taner Yildirmak,1 Arzu Kantürk,1 Deniz Arica,2 Demet Aydin,2 Naciye Demirel,2 Osman Yokuş21Department of Infectious Diseases and Clinical Microbiology, 2Department of Hematology, Ministry of Health Okmeydani Training and
Gedik H +7 more
doaj +1 more source
Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
Therapeutics and Clinical Risk Management, 2011 Maria Adriana Cataldo, Nicola PetrosilloSecond Infectious Diseases Division, National Institute for Infectious Diseases, “Lazzaro Spallanzani”, Rome, ItalyAbstract: Fungi are a frequent cause of nosocomial infections, with an ...
Maria Adriana Cataldo, Nicola Petrosillo
doaj +2 more sources
Antifungal prophylaxis in haematology patients [PDF]
Clinical Microbiology and Infection, 2006 ABSTRACTInvasive fungal infections (IFIs) are now the main cause of death from infection in cases of allogeneic stem-cell transplantation and an important cause of morbidity and mortality in patients with haematological malignancies undergoing chemotherapy.
de la Cámara, R.
openaire +3 more sources
Characteristics of antifungal utilization for hospitalized children in the United States
Antimicrobial Stewardship & Healthcare Epidemiology, 2022 Objective: To characterize antifungal prescribing patterns, including the indication for antifungal use, in hospitalized children across the United States.
Lourdes Eguiguren +7 more
doaj +1 more source
Journal of Fungi, 2023 Invasive fungal diseases (IFDs), in particular invasive mold infections, still pose considerable problems in the care of children and adolescents treated for cancer or undergoing hematopoietic cell transplantation.
Thomas Lehrnbecher +2 more
doaj +1 more source
BMC Infectious Diseases, 2022 Background Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT.
Mauricette Michallet +5 more
doaj +1 more source